Substance use & recovery

How Long Treatment Should Last, According to the Evidence

Save

"How long is rehab?" is one of the first questions families ask, and the honest answer unsettles the marketing: there isn't a number. Research ties better outcomes to longer engagement, not to a set stay, and the famous 28 days comes from a 1950s program, not from evidence. Here is what the science says about duration — and why the length a facility advertises can tell you more about its business than your needs.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How long should rehab last?

There is no fixed correct length for addiction treatment — but the research points firmly in one direction: outcomes get better the longer a person stays engaged. Federal evidence-based principles hold that remaining in treatment for an adequate time is critical, and that this generally means at least 90 days for residential or outpatient care, with longer durations producing better results 1. That is a floor and a trend, not a prescription; the right length depends on the person and is meant to be revisited as they progress.

What the evidence does not support is the idea that recovery is a fixed-length event you complete and then finish, the way you finish a course of antibiotics. The useful question is not "how many days?" but "how long does this person need to stay engaged, and what happens when the program ends?" A program that answers the length question with a single number for everyone is describing its product, not your needs.

Where the 28-day number came from

The 28-day rehab is the most recognizable length in American addiction treatment, and it has almost nothing to do with medicine. It descends from the abstinence-based residential model developed at Hazelden and related programs beginning in the late 1940s and 1950s — the lineage often called the Minnesota Model 2. The roughly month-long stay became a cultural default, reinforced later by insurance structures and by how programs packaged and billed care.

None of that history establishes that 28 days is the clinically optimal dose of treatment for anyone 2. It is a convention that stuck, not a finding that was tested and confirmed. Knowing where the number comes from matters because it is still marketed as if it were the standard course of care, the way a course of antibiotics has a defined length. Addiction does not work that way, and treating a fixed month as "complete" can end care exactly when the evidence says more time would help.

What the evidence actually says about duration

The clearest statement comes from federal research principles on effective treatment: no single approach is right for everyone, remaining in treatment for an adequate time is critical, and outcomes improve with duration 1. The commonly cited threshold is around 90 days of treatment for residential and outpatient care, below which the benefit tends to drop off 1. This is where the 90-day treatment guideline comes from — not from a facility's brochure but from the accumulated research on what predicts lasting change.

The same principles make a second point that reframes the length question entirely: medically assisted detox alone is not treatment and rarely leads to lasting recovery 1. So a short stay that is mostly withdrawal management is not a short course of treatment — it is barely the beginning of one. When people relapse quickly after a brief stay and conclude that "rehab doesn't work," what often happened is that they received detox and called it treatment. Duration only counts when the time is spent on the treatment itself.

Why 'length of rehab' is the wrong frame

Part of why the duration question is so hard to answer cleanly is that it assumes the wrong model. Landmark federal consensus describes addiction as a chronic condition, more like diabetes or hypertension than like a broken bone that heals in a set number of weeks 3. Chronic conditions are managed over time; they are not cured in a residential stay and then closed out.

That reframing changes what "long enough" means. A residential or outpatient episode is one phase, and what follows it — ongoing outpatient care, medication, mutual-help support, monitoring — is not an optional add-on but part of the treatment arc 3. Quality alcohol treatment, for instance, is described by federal guidance as spanning levels of intensity chosen by assessment, with behavioral therapy, medication, and mutual-help support all playing evidence-based roles across time 4. The honest answer to "how long should rehab be" is that the intensive part should last as long as the assessment and progress call for, and the supportive part is ongoing. A program that plans your discharge and continuing care from the start understands this; one that sells a finish line does not.

For opioid use disorder, duration is measured differently

For opioid use disorder, the whole framing of "length of rehab" can be misleading, because the core of effective treatment is medication that is not meant to be time-limited. The three FDA-approved medications — methadone, buprenorphine, and naltrexone — are the evidence-based foundation of care, and for many people they are taken for an extended period as ongoing treatment rather than a fixed course 5. Asking how many days of rehab someone with opioid use disorder needs can be like asking how many days of blood-pressure medication a person needs.

The evidence on retention makes the point concrete: at adequate doses, buprenorphine keeps people in treatment far better than placebo, and staying in treatment is itself protective 6. So for opioid use disorder, "duration" is better understood as how long someone stays on effective medication and engaged in care — a question about MOUD duration evidence, not about the length of a residential stay. A program that pressures a quick taper off medication to hit a discharge date is working against the evidence, not toward recovery.

What makes time in treatment actually count

Length matters, but only because it is a proxy for engagement in something that works. Time spent in a program that delivers evidence-based care — medication where indicated, behavioral therapies, real continuing-care planning — is time that pays off; the same weeks spent on amenities and unproven approaches are not. This is why the comparison of amenities vs quality matters more than the number of days on the calendar: a longer stay in a weak program is not better than a shorter stay in a strong one.

A few things distinguish time that counts:

  • The care is matched and re-matched by assessment, so the level and length adjust to how the person is actually doing rather than to a preset endpoint.
  • Detox is connected to treatment, not mistaken for it — the stay includes the actual work, not just getting through withdrawal 1.
  • Continuing care is built in from the start, so the intensive phase hands off to ongoing support instead of ending at a cliff 3.

When you evaluate a program, the questions to ask a rehab include how they decide when someone is ready to step down, and what happens after — because a good answer describes a process tied to progress, while a weak one just quotes a number of days.

Why a fast relapse doesn't mean treatment failed

When someone leaves a short program and returns to use within weeks, the easy conclusion is that treatment doesn't work — but that reading usually misdiagnoses what happened. Often the stay was mostly withdrawal management, which federal principles are clear is not treatment and rarely produces lasting recovery on its own 1. Ending care at the point detox finishes is stopping before the treatment has really started, and then blaming the treatment.

The chronic-condition frame helps here too. A recurrence is a feature of chronic illnesses that are undertreated, not proof that the illness is untreatable 3. A return to use after too little care is closer to blood pressure climbing when medication stops than to a cure that failed. The response the evidence supports is more or longer treatment and a better match — a step up in level, medication, stronger continuing care — not the conclusion that the person is beyond help 1. This is also why the choice between mat vs abstinence-only care matters when you judge what a short program actually delivered: a stay that withheld effective medication for opioid use disorder may have shortchanged the treatment no matter how many days it ran.

Length is set by assessment and progress, not a receipt

If length isn't a fixed number, what actually sets it? The answer is assessment and progress. Quality treatment is organized as levels of intensity chosen by assessment, and a person moves through them as they stabilize — a more intensive phase, then a step down to ongoing outpatient care, medication, and mutual-help support 4. The duration of each phase follows how the person is doing, which is why re-assessment along the way matters far more than the day count printed on an admission form.

That makes "how long should rehab be" partly a question about the whole arc of care, not a single stay. Federal principles hold that no single approach fits everyone and that staying engaged long enough is what predicts better outcomes 1. So the honest planning question is less "how many days will this program last" and more "how will care continue after it, and for how long." A program that can describe that arc — the intensive phase, the step-down, and the ongoing support that follows — is answering the length question the way the evidence would. A program that answers only with a number of days is answering a different question: how long it plans to bill.

None of this means length is unknowable at the start. An honest program can give a range and the reasoning behind it — this level for now, reassessed at set points, with a likely step-down once specific goals are met — and it will revise that estimate as the person progresses 1. What it will not do is promise that a fixed number of days equals a finished recovery, because the evidence does not support that promise 1. For a family, the most useful thing to listen for is whether the plan is built around the person's response to treatment or around a preset endpoint. The first is care that happens to have a length; the second is a length that happens to be called care.

Common questions

For some people it can be an adequate intensive phase, but federal research generally points to at least 90 days of treatment for better outcomes, with longer engagement doing better. A 30-day stay is more likely to work when it is genuine treatment connected to ongoing care afterward, rather than mostly detox followed by a discharge with no plan.

From federal research principles on effective addiction treatment, which find that remaining in treatment for an adequate time is critical and that outcomes improve with duration — generally at least 90 days for residential and outpatient care. It reflects accumulated research on what predicts lasting change, not a single study or a facility's marketing claim.

Longer engagement is associated with better outcomes, but only when the time is spent on effective treatment. A long stay in a weak program that relies on amenities or unproven methods is not better than a shorter stay in one delivering evidence-based care. Duration is a proxy for engagement in something that works, not a value on its own.

There is no set length, and the national approach is that this medication should not be arbitrarily time-limited. Many people stay on methadone, buprenorphine, or naltrexone for an extended period as ongoing treatment, similar to how a chronic condition is managed. Stopping is a decision made with a clinician based on stability, not a calendar.

Coverage limits often reflect the plan's utilization rules rather than clinical need, and a documented assessment supporting a longer or higher level of care can be the basis for an appeal. A short covered stay is also more effective when it is connected to lower-cost continuing care — outpatient treatment, medication, and mutual-help support — after the intensive phase ends.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When time is not the issue — get help now

  • Alcohol or benzodiazepine withdrawal with a seizure, confusion, hallucinations, or a racing heart — a medical emergency that comes before any question of program length
  • An overdose or someone hard to wake, breathing slowly, or with blue lips
  • Thoughts of suicide or self-harm during withdrawal or early recovery
  • A program pressuring a discharge or a quick medication taper to hit a date rather than based on how the person is doing

For a withdrawal seizure or suspected overdose, call 911. For thoughts of suicide, call or text 988 (the Suicide and Crisis Lifeline).

This article summarizes research on treatment duration for education. It is not medical advice and cannot replace an individualized plan from a qualified clinician who knows the person's situation.

References

  1. 1.National Institute on Drug Abuse (2018). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). National Institute on Drug Abuse (NIDA), NIH. linkThat remaining in treatment for an adequate time is critical, that outcomes improve with duration (generally at least 90 days for residential and outpatient care), and that medically assisted detox alone is not treatment and rarely leads to lasting recovery.
  2. 2.Hazelden Betty Ford Foundation (2020). The Minnesota Model. Hazelden Betty Ford Foundation. linkThe historical origin of the abstinence-based ~28-day residential program in the mid-twentieth-century Minnesota Model, not as evidence that 28 days is clinically optimal.
  3. 3.U.S. Department of Health and Human Services, Office of the Surgeon General (2016). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. U.S. Department of Health and Human Services (NCBI Bookshelf). linkThat addiction is a chronic condition managed over time and that treatment should be integrated into ongoing health care rather than treated as a one-time event.
  4. 4.National Institute on Alcohol Abuse and Alcoholism (2024). Types of Alcohol Treatment — Alcohol Treatment Navigator. National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH. linkThat quality treatment spans levels of intensity chosen by assessment, and that behavioral therapy, medication, and mutual-help support are all evidence-based options across time.
  5. 5.Substance Abuse and Mental Health Services Administration (2021). TIP 63: Medications for Opioid Use Disorder — Full Document. SAMHSA Treatment Improvement Protocol 63. linkThat the three FDA-approved medications for opioid use disorder are methadone, buprenorphine, and naltrexone, and that they are the evidence-based foundation of care often taken over an extended period.
  6. 6.Mattick RP, Breen C, Kimber J, Davoli M (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD002207.pub4That buprenorphine at adequate doses retains patients in treatment far better than placebo, supporting that ongoing engagement on effective medication is what matters for opioid use disorder.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy